Vitamin D3 for Life

Live Enlightened

Article

Vitamin D Insufficiency as a Functional Intermediate State: Study Summary

Previous related pageVitamin D Insufficiency as a Functional Intermediate State: Full StudyNext related pageVitamin D Insufficiency: Physiology, Thresholds and Interpretation: Evidence Synthesis
Study at a glance

What does vitamin D insufficiency mean?

Vitamin D insufficiency describes a middle range between adequate supply and severe deficiency. This article reviews studies of hormone responses, calcium absorption and blood measurements. It asks whether this middle range identifies the same health problem in everyone.

How can the body adjust when vitamin D supply falls?

As vitamin D supply falls, the body can adjust hormone activity to help preserve calcium balance and active vitamin D. Parathyroid hormone is part of this response. These adjustments can maintain function for a time, but lower supply may make it harder for the body to keep these levels steady. The changes do not occur in exactly the same way in every person.

Did the studies find one clear boundary for vitamin D insufficiency?

Studies of parathyroid hormone did not identify one vitamin D level that consistently separated adequate function from a problem. A review of 70 studies found widely varying proposed cut-offs. Studies of calcium absorption also did not establish a consistent boundary at 30 ng/mL. A separate study found clearer changes in blood measurements around the lower level of 30 nmol/L.

Does a vitamin D insufficiency label prove disease?

An insufficiency label may indicate reduced vitamin D supply and possible risk, but it does not by itself prove disease. Understanding the result depends on how low it is, whether it stays low and the person’s circumstances. Measurement uncertainty also matters. The evidence does not establish one boundary that applies to everyone.

Read the full article below ↓

Vitamin D insufficiency is best understood as an intermediate region of vitamin D supply rather than a universal disease state. As 25-hydroxyvitamin D [25(OH)D] falls, the body can increase compensatory mechanisms such as PTH-driven calcium conservation and regulation of active vitamin D. That means function may be preserved for a time even as supply becomes less secure. This is the physiological background to Vitamin D Insufficiency Explained. For the full evidence review, see Vitamin D Insufficiency as a Functional Intermediate State: Full Study.

Why an intermediate state is biologically plausible

Severe vitamin D deficiency can impair calcium and phosphate handling and, when prolonged, contribute to secondary hyperparathyroidism and defective bone mineralisation. Before that severe state is reached, physiology can compensate. This creates a genuine continuum in which progressively lower vitamin D supply may increase regulatory strain without producing the same abnormalities in every person.

That continuum helps separate Vitamin D Deficiency Definitions from the broader idea of insufficiency. Deficiency is most convincing where the probability of adverse physiological consequences is high; insufficiency occupies the less certain region above it.

Why there is no universal functional cutoff

Sai and colleagues found an inverse relationship between 25(OH)D and PTH but no single PTH-suppression threshold in their cohort, while a review of 70 studies showed widely varying thresholds. Hansen and Gallagher tested calcium absorption and found that correcting values commonly labelled insufficient did not reveal a consistent 30 ng/mL functional boundary. Shah and colleagues found their clearest biochemical breakpoint much lower, around 30 nmol/L.

Together, these results explain why Vitamin D Thresholds vs Targets matter: a useful clinical or policy threshold can exist even when biology itself changes continuously.

How to interpret insufficiency

An insufficiency label should therefore be read as a signal of reduced supply and possible vulnerability, not proof of a discrete physiological failure. The meaning of the result depends on how low it is, persistence, clinical context, and measurement uncertainty. Limitations of Vitamin D Blood Tests and Population Reference Ranges Explained help explain why a small movement across a category boundary should not automatically be treated as a major biological change.

The central conclusion is that the intermediate state is physiologically credible, but its boundaries are not universal. The strongest evidence is for a gradient of increasing compensatory demand and risk as vitamin D status falls.

Scientific sources and publication details

Karen E Hansen et al. Vitamin D Insufficiency: Disease or No Disease?. Journal of Bone and Mineral Research. 2008;23(7):1052 to 1060. PMID 18302509; PMCID PMC2574556; DOI 10.1359/JBMR.080230.

A J Sai et al. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. Journal of Clinical Endocrinology & Metabolism. 2011;96(3):E436: E446. PMID 21159838; PMCID PMC3047227; DOI 10.1210/jc.2010-1886.

J Christopher Gallagher et al. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550 to 3556. PMID 22855333; PMCID PMC3462946; DOI 10.1210/jc.2012-2020.

Sonali Shah et al. Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease. Journal of Clinical Endocrinology & Metabolism. 2017;102(7):2321 to 2328. PMID 28379394; DOI 10.1210/jc.2016-3189.

Related reading

Original sources

Source

Vitamin D Insufficiency: Disease or No Disease?

Published in Journal of Bone and Mineral Research (2008).

Publication details

Karen E Hansen et al. Vitamin D Insufficiency: Disease or No Disease?. Journal of Bone and Mineral Research. 2008;23(7):1052 to 1060. PMID 18302509; PMCID PMC2574556; DOI 10.1359/JBMR.080230.

Read more →
Source

The Effect of Vitamin D on Calcium Absorption in Older Women

Published in Journal of Clinical Endocrinology & Metabolism (2012).

Publication details

J Christopher Gallagher et al. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550 to 3556. PMID 22855333; PMCID PMC3462946; DOI 10.1210/jc.2012-2020.

Read more →